| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |